← Back to headlines
Eli Lilly-Backed Scribe Therapeutics Jumps 67% After Upsized IPO
Scribe Therapeutics, a company backed by Eli Lilly, saw its stock jump 67% following an upsized initial public offering.
24 Jul, 20:09 — 24 Jul, 20:09
Sources
Showing 1 of 1 sources
